Repotrectinib | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Repotrectinib
FDF Dossiers

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

pharmacompass-1-m-2025-11-24

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Repotrectinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 4 NDC API, 1 Listed Suppliers

5 API Suppliers
4 NDC API
1 Listed Suppliers

DEVELOPMENTS

38 Drugs in Development

38 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 2 FDA Orange Book, 2 Europe

4 FDF Dossiers
2 FDA Orange Book
2 Europe

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 32 News #PharmaBuzz

3 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
32 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Annual Reports

2 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

12 US Patents, 6 US Exclusivities, 4 Health Canada Patents

12 US Patents
6 US Exclusivities
4 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 2Bristol Laboratories Ltd

02 2Bristol Myers Squibb

filter Dosage Reset all filters

4 All

01 2CAPSULE;ORAL

02 2Capsule

filter Regulatory Info Reset all filters

4 All

01 2Approved

02 2RX

filter Brand Name Reset all filters

4 All

01 2AUGTYRO

02 2Augtyro

filter Country Reset all filters

4 All

01 2Sweden

02 2USA

List of Suppliers

Product Main Page

01

Bristol Laboratories Ltd

CTAD25

Not Confirmed

Bristol Laboratories Ltd

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 2023-11-15

Application Number : 218213

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bristol Laboratories Ltd

CTAD25

Not Confirmed

Bristol Laboratories Ltd

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : RX

Registration Country : USA

REPOTRECTINIB

Brand Name : AUGTYRO

Dosage Form : CAPSULE;ORAL

Dosage Strength : 160MG

Packaging :

Approval Date : 2024-06-11

Application Number : 218213

Regulatory Info : RX

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bristol Myers Squibb

CTAD25

Not Confirmed

Bristol Myers Squibb

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 160mg

Packaging :

Approval Date : 13/01/2025

Application Number : 20231127000145

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bristol Myers Squibb

CTAD25

Not Confirmed

Bristol Myers Squibb

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Repotrektinib

Brand Name : Augtyro

Dosage Form : Capsule

Dosage Strength : 40mg

Packaging :

Approval Date : 13/01/2025

Application Number : 20231127000138

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!